Work

Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non–Small-Cell Lung Cancer

Year: 2016

Type: article

Study design: Study Protocol

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2016.05.023

Authors: Edward B. Garon, Martin Reck, Luis Paz-Ares, Santiago Ponce, Jesus Corral Jaime, Oscar Juan, Ernest Nadal, Pablo Lee, Rita Dalal, Jingyi Liu, Shuang He, Joseph Treat, Kazuhiko Nakagawa

Institutions: University of California, Los Angeles, German Center for Lung Research, LungenClinic Grosshansdorf, Hospital Universitario 12 De Octubre, Hospital Universitario Virgen del Rocío, Hospital Universitari i Politècnic La Fe, Institut Català d'Oncologia, Eli Lilly (United States), Kindai University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Instituto de Salud Carlos III

OpenAlex ID: W2415849645

FWCI: 1.588

Cites: 18

Cited by: 10

Related to: 10